PAOPA is a novel dopamine D2 receptor modulator and L-proline-L-leucine-glycine amide (PLG) peptide mimetic that prevents and reverses behavioral and biochemical abnormalities in preclinical animal models of schizophrenia sensitized to amphetamine. PAOPA has been used in the study of schizophrenia and extrapyramidal dysfunction.
Molekulargewicht:
254.29
Reinheit:
>99.99%
CAS Nummer:
[114200-31-6]
Formel:
C11H18N4O3
Target-Kategorie:
Dopamine Receptor
T23121
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten